• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thromboembolism and the Oxford-AstraZeneca COVID-19 vaccine: side-effect or coincidence?

作者信息

Østergaard Søren Dinesen, Schmidt Morten, Horváth-Puhó Erzsébet, Thomsen Reimar Wernich, Sørensen Henrik Toft

机构信息

Department of Affective Disorders, Aarhus University Hospital, 8200 Aarhus, Denmark; Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark.

Department of Cardiology, Aarhus University Hospital, 8200 Aarhus, Denmark; Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.

出版信息

Lancet. 2021 Apr 17;397(10283):1441-1443. doi: 10.1016/S0140-6736(21)00762-5. Epub 2021 Mar 30.

DOI:10.1016/S0140-6736(21)00762-5
PMID:33798498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8009607/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ce/8009607/3cb02f08ebc7/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ce/8009607/3cb02f08ebc7/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07ce/8009607/3cb02f08ebc7/fx1_lrg.jpg

相似文献

1
Thromboembolism and the Oxford-AstraZeneca COVID-19 vaccine: side-effect or coincidence?血栓栓塞与牛津大学-阿斯利康新冠疫苗：副作用还是巧合？
Lancet. 2021 Apr 17;397(10283):1441-1443. doi: 10.1016/S0140-6736(21)00762-5. Epub 2021 Mar 30.
2
Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study.非洲埃塞俄比亚医护人员报告的牛津阿斯利康 COVID-19 疫苗的副作用：一项横断面研究。
Front Public Health. 2022 Jul 19;10:937794. doi: 10.3389/fpubh.2022.937794. eCollection 2022.
3
Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.对牛津-阿斯利康疫苗的安全性担忧后，对 COVID-19 疫苗的持续意愿。
Dan Med J. 2021 Mar 31;68(5):A03210292.
4
Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database.关于Moderna、辉瑞和牛津-阿斯利康新冠疫苗报告的血栓形成不良事件：欧洲药物警戒数据库中发生率和临床结果的比较
Vaccines (Basel). 2021 Nov 15;9(11):1326. doi: 10.3390/vaccines9111326.
5
The impact of pausing the Oxford-AstraZeneca COVID-19 vaccine on uptake in Europe: a difference-in-differences analysis.暂停使用牛津-阿斯利康 COVID-19 疫苗对欧洲接种率的影响：一项差分分析。
Eur J Public Health. 2022 Aug 1;32(4):648-654. doi: 10.1093/eurpub/ckac039.
6
Thromboembolism and the Oxford-AstraZeneca vaccine.血栓栓塞与牛津-阿斯利康疫苗。
BMJ. 2021 May 5;373:n1159. doi: 10.1136/bmj.n1159.
7
Prospective Evaluation of Side-Effects Following the First Dose of Oxford/AstraZeneca COVID-19 Vaccine among Healthcare Workers in Saudi Arabia.沙特阿拉伯医护人员接种第一剂牛津/阿斯利康新冠疫苗后副作用的前瞻性评估
Vaccines (Basel). 2022 Jan 30;10(2):223. doi: 10.3390/vaccines10020223.
8
Tracking Side Effects of the COVID-19 Vaccine in Mymensingh District of Bangladesh.追踪孟加拉国迈门辛地区 COVID-19 疫苗的副作用。
Mymensingh Med J. 2022 Jan;31(1):1-9.
9
Case of lichen planus pigmentosus-inversus after Oxford-AstraZeneca COVID-19 vaccine: cause or coincidence?牛津-阿斯利康新冠疫苗接种后发生色素性扁平苔藓-反向型病例：是原因还是巧合？
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e514-e516. doi: 10.1111/jdv.18058. Epub 2022 Mar 16.
10
Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect?阿斯利康新冠疫苗在一名母乳喂养女婴中引起的迟发性皮肤不良反应：巧合还是罕见效应？
Vaccines (Basel). 2022 Apr 13;10(4):602. doi: 10.3390/vaccines10040602.

引用本文的文献

1
Impact of COVID-19 vaccination on cancer patients: safety, efficacy, and long-term effects.2019冠状病毒病疫苗接种对癌症患者的影响：安全性、有效性及长期影响
Support Care Cancer. 2025 Aug 4;33(8):753. doi: 10.1007/s00520-025-09783-1.
2
Anticoagulant prescribing trends, bleeding events, and reversal agent use in pediatric patients: A retrospective, real-world study.儿科患者的抗凝药物处方趋势、出血事件及逆转剂使用情况：一项回顾性真实世界研究。
PLoS One. 2025 May 8;20(5):e0323137. doi: 10.1371/journal.pone.0323137. eCollection 2025.
3
Respiratory delivered vaccines: Current status and perspectives in rational formulation design.

本文引用的文献

1
Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots.新冠疫情：有报道称出现血栓后，欧洲多国暂停使用牛津-阿斯利康疫苗。
BMJ. 2021 Mar 11;372:n699. doi: 10.1136/bmj.n699.
2
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.一剂接种和加强针接种时间对 ChAdOx1 nCoV-19（阿斯利康）疫苗免疫原性和有效性的影响：四项随机试验的 pooled 分析。
Lancet. 2021 Mar 6;397(10277):881-891. doi: 10.1016/S0140-6736(21)00432-3. Epub 2021 Feb 19.
3
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
呼吸道给药疫苗：合理剂型设计的现状与展望
Acta Pharm Sin B. 2024 Dec;14(12):5132-5160. doi: 10.1016/j.apsb.2024.08.026. Epub 2024 Nov 4.
4
Side effects associated with homogenous and heterogenous doses of Oxford-AstraZeneca vaccine among adults in Bangladesh: an observational study.在孟加拉国成年人中，与牛津-阿斯利康疫苗同源和异源剂量相关的副作用：一项观察性研究。
Sci Rep. 2024 Oct 11;14(1):23794. doi: 10.1038/s41598-024-75833-z.
5
Grappling Covishield fear in India: the urgent need for strong countermeasures to build vaccine confidence.应对印度对科维希德疫苗的恐惧：迫切需要采取有力对策以建立疫苗信心。
Lancet Reg Health Southeast Asia. 2024 Jul 11;27:100447. doi: 10.1016/j.lansea.2024.100447. eCollection 2024 Aug.
6
New-onset psychosis following COVID-19 vaccination: a systematic review.新冠病毒疫苗接种后新发精神病：一项系统综述
Front Psychiatry. 2024 Apr 12;15:1360338. doi: 10.3389/fpsyt.2024.1360338. eCollection 2024.
7
Attitudes toward COVID-19 vaccines during pregnancy and breastfeeding.妊娠期和哺乳期对 COVID-19 疫苗的态度。
Front Public Health. 2024 Mar 1;12:1286891. doi: 10.3389/fpubh.2024.1286891. eCollection 2024.
8
Case Study of Autopsy Findings in a Population of Post-COVID-19 Vaccination in Thailand.泰国接种 COVID-19 疫苗后的人群尸检结果的病例研究。
Am J Forensic Med Pathol. 2024 Mar 1;45(1):45-50. doi: 10.1097/PAF.0000000000000900. Epub 2023 Dec 21.
9
Using Trajectories of Bedside Vital Signs to Identify COVID-19 Subphenotypes.利用床边生命体征轨迹识别新冠病毒疾病亚表型
Chest. 2024 Mar;165(3):529-539. doi: 10.1016/j.chest.2023.09.020. Epub 2023 Sep 23.
10
Hesitancy towards the COVID-19 vaccine among health care practitioners in the Kingdom of Saudi Arabia: a cross-sectional study.沙特阿拉伯医护人员对接种 COVID-19 疫苗的犹豫态度：一项横断面研究。
F1000Res. 2023 Jun 12;11:24. doi: 10.12688/f1000research.74575.6. eCollection 2022.
在年轻和老年成年人中进行的一次单盲、随机、对照、2/3 期试验中，观察 ChAdOx1 nCoV-19 疫苗在初免-加强免疫方案中的安全性和免疫原性（COV002）。
Lancet. 2021 Dec 19;396(10267):1979-1993. doi: 10.1016/S0140-6736(20)32466-1. Epub 2020 Nov 19.
4
The Danish health care system and epidemiological research: from health care contacts to database records.丹麦医疗保健系统与流行病学研究：从医疗保健接触到数据库记录。
Clin Epidemiol. 2019 Jul 12;11:563-591. doi: 10.2147/CLEP.S179083. eCollection 2019.
5
Venous Thromboembolism in Denmark: Seasonality in Occurrence and Mortality.丹麦的静脉血栓栓塞：发病率和死亡率的季节性
TH Open. 2019 Jun 18;3(2):e171-e179. doi: 10.1055/s-0039-1692399. eCollection 2019 Apr.
6
Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort study.丹麦脾静脉血栓形成患者的出血风险和动脉心血管事件：一项基于人群的队列研究。
Lancet Haematol. 2018 Oct;5(10):e441-e449. doi: 10.1016/S2352-3026(18)30133-9. Epub 2018 Sep 7.
7
Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study.丹麦国家患者登记处心血管疾病诊断的阳性预测值：一项验证研究。
BMJ Open. 2016 Nov 18;6(11):e012832. doi: 10.1136/bmjopen-2016-012832.
8
The Danish National Patient Registry: a review of content, data quality, and research potential.丹麦国家患者登记处：内容、数据质量及研究潜力综述
Clin Epidemiol. 2015 Nov 17;7:449-90. doi: 10.2147/CLEP.S91125. eCollection 2015.
9
Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009).静脉血栓栓塞症发生率的长期变化趋势：伍斯特静脉血栓栓塞症研究（1985-2009）。
Am J Med. 2014 Sep;127(9):829-39.e5. doi: 10.1016/j.amjmed.2014.03.041. Epub 2014 May 6.
10
Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort.真实世界人群中静脉血栓栓塞症的发生率和死亡率：Q-VTE 研究队列。
Am J Med. 2013 Sep;126(9):832.e13-21. doi: 10.1016/j.amjmed.2013.02.024. Epub 2013 Jul 3.